Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary CNS Lymphoma (PCNSL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01182415
What this trial is testing

High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaCNS Lymphoma
Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT04737889
What this trial is testing

Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00002621
What this trial is testing

Interferon Alfa in Treating Children With HIV-Related Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 8
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Testing effectiveness (Phase 2)Looking for participantsNCT06556199
What this trial is testing

Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma

Who this might be right for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 38
Not applicableStudy completedNCT00226304
What this trial is testing

Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma

Who this might be right for
HIV InfectionsLymphoma, AIDS-Related
National Institutes of Health Clinical Center (CC) 120
Testing effectiveness (Phase 2)UnknownNCT01735747
What this trial is testing

Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Central Nervous System Tumors
Rongjie Tao 16
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Not applicableLooking for participantsNCT05841914
What this trial is testing

Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma

Who this might be right for
Vitreoretinal Lymphoma
Vinodh Kakkassery, MD 220
Not applicableUnknownNCT05117814
What this trial is testing

Zanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma

Who this might be right for
CNS Lymphoma
Peking University People's Hospital 20
Early research (Phase 1)Ended earlyNCT05242146
What this trial is testing

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

Who this might be right for
CNS Lymphoma
GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT02301364
What this trial is testing

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Who this might be right for
LymphomaPrimary Central Nervous System LymphomaRecurrent/Refractory Secondary Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 4
Post-approval studies (Phase 4)UnknownNCT04083066
What this trial is testing

Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Mingzhi Zhang 20
Not applicableNot Yet RecruitingNCT07710131
What this trial is testing

Neurocognitive Assessment CNSL and LGG

Who this might be right for
PCNSLBrain TumorCognitive Dysfunction+2 more
Dana-Farber Cancer Institute 36
Early research (Phase 1)Looking for participantsNCT06712810
What this trial is testing

Q702 for the Treatment of Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic 46
Testing effectiveness (Phase 2)Looking for participantsNCT07015242
What this trial is testing

The Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 65
Testing effectiveness (Phase 2)WithdrawnNCT00712062
What this trial is testing

Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
University of Florida
Testing effectiveness (Phase 2)Study completedNCT00193973
What this trial is testing

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Trans Tasman Radiation Oncology Group 20
Large-scale testing (Phase 3)Looking for participantsNCT02836158
What this trial is testing

Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing 100
Next Page